Bone Wax as a Risk Factor for Surgical-Site Infection Following Neurospinal Surgery

Infection Control and Hospital Epidemiology

Volumn 25, Issue 4, 2004, Pages 346-348

  Gibbs, Laurel ^a   Kakis, Anthony ^a   Weinstein, Philip ^c   Conte Jr , John E ^a,b,d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE WAX; HEMOSTATIC AGENT;

ARTICLE; HUMAN; INFECTION RISK; NEUROSURGERY; RISK FACTOR; SURGICAL INFECTION;

CROSS INFECTION; DRUG COMBINATIONS; HEMOSTATICS; HUMANS; NEUROSURGICAL PROCEDURES; PALMITATES; RISK FACTORS; SURGICAL WOUND INFECTION; WAXES;

EID: 1942516395     PISSN: 0899823X     EISSN: None     Source Type: Journal    
DOI: 10.1086/502403     Document Type: Article

References (12)

1. Katz SE, Rootman J. Adverse effects of bone wax in surgery of the orbit. Ophthal Plast Reconstr Surg 1996;12:121-126.
2. Robicsek F, Daugherty HK, Cook JW, et al. Mycobacterium fortuitum epidemics after open-heart surgery. J Thorac Cardiovasc Surg 1978;75:91-96.
3. Mangram AJ, Horan TC, Pearson ML, Silver LC, Jarvis WR. Guideline for prevention of surgical site infection, 1999: Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1999;20:250-278.
4. National Nosocomial Infections Surveillance (NNIS) System report: data summary from January 1992-June 2002, issued August 2002. Am J Infect Control 2002;30:458-475.
5. Apisarnthanarak A, Jones M, Waterman BM, Carroll CM, Bernardi R, Fraser VJ. Risk factors for surgical-site infections in a community hospital: a case-control study. Infect Control Hosp Epidemiol 2003;24:31-36.
6. Olsen MA, Mayfield J, Lauryssen C, et al. Risk factors for surgical site infection in spinal surgery. J Neurosurg 2003;98(suppl):149-155.
7. Momata Y, Miyamota, Ishikawa K, et al. Evaluation of feasibility of hydroxyapatite putty as a local hemostatic agent for bone. J Biomed Mater Res 2002;63:542-547.
8. Patel RB, Kwatler JA, Hodosh RM. Bone wax as a cause of body granuloma in the cerebellopontine angle: case illustration. J Neurosurg 2000;92:362.
9. Nelson DR, Buxton TB, Quyen NL, Rissing P. The promotional effect of bone wax on experimental Staphylococcus aureus osteomyelitis. J Thorac Cardiovasc Surg 1991;99:977-980.
10. Anfinsen OG, Sudmann B, Rait M, Bang F, Sudmann E. Complications secondary to the use of standard bone wax in seven patients. J Foot Ankle Surg 1993;32:505-508.
11. Johnson P, Fromm D. Effects of bone wax on bacterial clearance. Surgery 1981;89:206-209.
12. Baldauf R, Kanat IO. The use of bone wax. J Foot Surg 1986;25:456-458.